HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 303 filers reported holding HAEMONETICS CORP in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,556,109 | +0.4% | 62,024 | -7.3% | 0.00% | -33.3% |
| Q2 2023 | $5,533,990 | 0.0% | 66,876 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $5,533,990 | +22.0% | 66,876 | +15.9% | 0.00% | +50.0% |
| Q4 2022 | $4,536,925 | -99.9% | 57,685 | +6.7% | 0.00% | 0.0% |
| Q3 2022 | $4,001,618,000 | +0.3% | 54,054 | -11.7% | 0.00% | 0.0% |
| Q2 2022 | $3,990,581,000 | +2.2% | 61,224 | -0.9% | 0.00% | 0.0% |
| Q1 2022 | $3,905,478,000 | +20.0% | 61,776 | +0.7% | 0.00% | +100.0% |
| Q4 2021 | $3,254,799,000 | -24.3% | 61,365 | +0.8% | 0.00% | -50.0% |
| Q3 2021 | $4,299,142,000 | +5.3% | 60,903 | -0.5% | 0.00% | 0.0% |
| Q2 2021 | $4,080,834,000 | -55.6% | 61,237 | -26.1% | 0.00% | -50.0% |
| Q1 2021 | $9,200,175,000 | -8.6% | 82,877 | -2.2% | 0.00% | -20.0% |
| Q4 2020 | $10,062,519,000 | +77.7% | 84,737 | +30.6% | 0.01% | +66.7% |
| Q3 2020 | $5,662,614,000 | -43.2% | 64,901 | -41.7% | 0.00% | -50.0% |
| Q2 2020 | $9,970,000,000 | +9.1% | 111,322 | +21.4% | 0.01% | -14.3% |
| Q1 2020 | $9,137,427,000 | -21.3% | 91,686 | -9.2% | 0.01% | 0.0% |
| Q4 2019 | $11,606,623,000 | -14.2% | 101,015 | -5.8% | 0.01% | -22.2% |
| Q3 2019 | $13,532,551,000 | +52.6% | 107,282 | +45.6% | 0.01% | +50.0% |
| Q2 2019 | $8,867,251,000 | +161.5% | 73,685 | +90.1% | 0.01% | +100.0% |
| Q1 2019 | $3,390,376,000 | -0.7% | 38,756 | +13.5% | 0.00% | 0.0% |
| Q4 2018 | $3,415,108,000 | -23.7% | 34,134 | -12.6% | 0.00% | 0.0% |
| Q3 2018 | $4,476,068,000 | +29.7% | 39,065 | +1.5% | 0.00% | 0.0% |
| Q2 2018 | $3,450,438,000 | +22.0% | 38,475 | -0.5% | 0.00% | +50.0% |
| Q1 2018 | $2,829,098,000 | +41.6% | 38,670 | +12.4% | 0.00% | 0.0% |
| Q4 2017 | $1,997,313,000 | +47.9% | 34,389 | +14.3% | 0.00% | +100.0% |
| Q3 2017 | $1,350,092,000 | +21.4% | 30,089 | +6.9% | 0.00% | 0.0% |
| Q2 2017 | $1,111,762,000 | -0.0% | 28,153 | +2.7% | 0.00% | 0.0% |
| Q1 2017 | $1,112,064,000 | +134695.6% | 27,411 | +33.6% | 0.00% | 0.0% |
| Q4 2016 | $825,000 | -35.4% | 20,519 | -41.8% | 0.00% | 0.0% |
| Q3 2016 | $1,277,000 | +25.0% | 35,261 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $1,022,000 | -1.8% | 35,261 | +18.5% | 0.00% | 0.0% |
| Q1 2016 | $1,041,000 | -13.5% | 29,748 | -20.3% | 0.00% | 0.0% |
| Q4 2015 | $1,204,000 | +17.1% | 37,342 | +17.4% | 0.00% | 0.0% |
| Q3 2015 | $1,028,000 | +6.6% | 31,798 | +36.5% | 0.00% | 0.0% |
| Q2 2015 | $964,000 | -88.6% | 23,298 | -87.6% | 0.00% | -87.5% |
| Q1 2015 | $8,447,000 | -2.1% | 188,050 | -18.5% | 0.01% | 0.0% |
| Q4 2014 | $8,632,000 | -14.1% | 230,687 | -19.8% | 0.01% | -20.0% |
| Q3 2014 | $10,049,000 | +193.6% | 287,749 | +196.5% | 0.01% | +233.3% |
| Q2 2014 | $3,423,000 | +464.9% | 97,038 | +421.8% | 0.00% | +200.0% |
| Q1 2014 | $606,000 | -17.3% | 18,598 | +6.9% | 0.00% | 0.0% |
| Q4 2013 | $733,000 | +5.6% | 17,398 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $694,000 | -3.5% | 17,398 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $719,000 | – | 17,398 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LGT CAPITAL PARTNERS LTD. | 1,216,059 | $64,500,000 | 1.72% |
| HEARTLAND ADVISORS INC | 406,192 | $21,544,000 | 1.26% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 200,000 | $10,608,000 | 1.22% |
| Aurora Investment Counsel | 32,149 | $1,705,000 | 1.01% |
| Endurant Capital Management LP | 73,914 | $3,920,000 | 0.95% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 135,000 | $7,160,000 | 0.82% |
| ARMISTICE CAPITAL, LLC | 872,000 | $46,251,000 | 0.76% |
| Summit Creek Advisors LLC | 131,357 | $6,967,000 | 0.70% |
| Dean Capital Management | 15,309 | $812,000 | 0.70% |
| Keene & Associates, Inc. | 11,720 | $622,000 | 0.54% |